Biomarkers and Antimicrobial Stewardship – The Synergies to Diagnose Sepsis and to Prevent AMR (S9)
Biomarkers and Antimicrobial Stewardship – The Synergies to Diagnose Sepsis and to Prevent AMR (S9)
Session 9 from the 4th World Sepsis Congress. To go directly to a specific speaker/talk, please use these chapter markers:00:00 Intro
00:55 Louise Thwaites – Introduction
02:47 Silvia Bertagnolio – The Key Drivers of Antimicrobial Resistance
27:55 Ron Daniels – The Potential and Barriers to Antibiotic Stewardship
44:25 Evdoxia Kyriazopoulou – The Potential of Biomarkers for Antimicrobials – Use and Diagnosis
1:01:09 Peter Pickkers – The Role of Biomarkers for Risk Stratification
1:18:16 Tom van der Poll – The Evidence for the Role of Transcriptional Diagnostics
All talks are also available as a podcast – just search for World Sepsis Congress in your podcast app of choice.
Direct link: https://podcasts.apple.com/us/podcast/4th-world-sepsis-congress/id1155062518
Session 10 will follow momentarily. Sessions 11 and 12 will follow on June 6, 2023. The full release schedule is available at https://www.worldsepsiscongress.org/watch
Thanks for watching and sharing.
The 4th World Sepsis Congress – One Global Health Threat: Sepsis, Pandemics, and Antimicrobial Resistance is a project by the Global Sepsis Alliance, initiator of World Sepsis Day and World Sepsis Congress.
Stop Sepsis – Save Lives
Access Non-GMO, antigen-free, generic antiviral medication formulas used in Moderna's Spikevax.
VirusTC is a retail provider of concentrated generic antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA approved formulas that are compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Our products and services are used by Fred Hutch Cancer Center, Mayo Clinic, John Hopkins, University Hospitals, the United States Military, and professional sports. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.